Design, Synthesis, Molecular Docking, and Biological Evaluation of Pyrazole Hybrid Chalcone Conjugates as Potential Anticancer Agents and Tubulin Polymerization Inhibitors. 2022

Md Jahangir Alam, and Ozair Alam, and Ahmad Perwez, and Moshahid Alam Rizvi, and Mohd Javed Naim, and Vegi G M Naidu, and Mohd Imran, and Mohammed M Ghoneim, and Sultan Alshehri, and Faiyaz Shakeel
Medicinal Chemistry and Molecular Modeling Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.

Some (E)-3-(3-(4-(benzyloxy)phenyl)-1-phenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-one conjugates 5a-r were designed; synthesized; characterized by 1H, 13C NMR, and ESI-MS; and evaluated for tubulin polymerization inhibitory activity and in vitro cytotoxicity against breast (MCF-7), cervical (SiHa), and prostate (PC-3) cancer cell lines, as well as a normal cell line (HEK-293T). The compounds were also tested to determine their binding modes at the colchicine-binding site of tubulin protein (PDB ID-3E22), for in silico ADME prediction, for bioactivity study, and for PASS prediction studies. Among all the synthesized conjugates, compound 5o exhibited excellent cytotoxicity with an IC50 value of 2.13 ± 0.80 µM (MCF-7), 4.34 ± 0.98 µM (SiHa), and 4.46 ± 0.53 µM (PC-3) against cancer cell lines. The compound did not exhibit significant toxicity to the HEK cells. Results of the in silico prediction revealed that the majority of the conjugates possessed drug-like properties.

UI MeSH Term Description Entries

Related Publications

Md Jahangir Alam, and Ozair Alam, and Ahmad Perwez, and Moshahid Alam Rizvi, and Mohd Javed Naim, and Vegi G M Naidu, and Mohd Imran, and Mohammed M Ghoneim, and Sultan Alshehri, and Faiyaz Shakeel
January 2020, Bioorganic chemistry,
Md Jahangir Alam, and Ozair Alam, and Ahmad Perwez, and Moshahid Alam Rizvi, and Mohd Javed Naim, and Vegi G M Naidu, and Mohd Imran, and Mohammed M Ghoneim, and Sultan Alshehri, and Faiyaz Shakeel
July 2021, Bioorganic chemistry,
Md Jahangir Alam, and Ozair Alam, and Ahmad Perwez, and Moshahid Alam Rizvi, and Mohd Javed Naim, and Vegi G M Naidu, and Mohd Imran, and Mohammed M Ghoneim, and Sultan Alshehri, and Faiyaz Shakeel
March 2015, European journal of medicinal chemistry,
Md Jahangir Alam, and Ozair Alam, and Ahmad Perwez, and Moshahid Alam Rizvi, and Mohd Javed Naim, and Vegi G M Naidu, and Mohd Imran, and Mohammed M Ghoneim, and Sultan Alshehri, and Faiyaz Shakeel
January 2023, Assay and drug development technologies,
Md Jahangir Alam, and Ozair Alam, and Ahmad Perwez, and Moshahid Alam Rizvi, and Mohd Javed Naim, and Vegi G M Naidu, and Mohd Imran, and Mohammed M Ghoneim, and Sultan Alshehri, and Faiyaz Shakeel
December 2022, Bioorganic chemistry,
Md Jahangir Alam, and Ozair Alam, and Ahmad Perwez, and Moshahid Alam Rizvi, and Mohd Javed Naim, and Vegi G M Naidu, and Mohd Imran, and Mohammed M Ghoneim, and Sultan Alshehri, and Faiyaz Shakeel
December 2020, Iranian journal of basic medical sciences,
Md Jahangir Alam, and Ozair Alam, and Ahmad Perwez, and Moshahid Alam Rizvi, and Mohd Javed Naim, and Vegi G M Naidu, and Mohd Imran, and Mohammed M Ghoneim, and Sultan Alshehri, and Faiyaz Shakeel
September 2019, Chemical biology & drug design,
Md Jahangir Alam, and Ozair Alam, and Ahmad Perwez, and Moshahid Alam Rizvi, and Mohd Javed Naim, and Vegi G M Naidu, and Mohd Imran, and Mohammed M Ghoneim, and Sultan Alshehri, and Faiyaz Shakeel
December 2020, Bioorganic chemistry,
Md Jahangir Alam, and Ozair Alam, and Ahmad Perwez, and Moshahid Alam Rizvi, and Mohd Javed Naim, and Vegi G M Naidu, and Mohd Imran, and Mohammed M Ghoneim, and Sultan Alshehri, and Faiyaz Shakeel
December 2015, Bioorganic chemistry,
Md Jahangir Alam, and Ozair Alam, and Ahmad Perwez, and Moshahid Alam Rizvi, and Mohd Javed Naim, and Vegi G M Naidu, and Mohd Imran, and Mohammed M Ghoneim, and Sultan Alshehri, and Faiyaz Shakeel
September 2017, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!